Net profit of Mangalam Drugs and Organics reported to Rs 3.55 crore in the quarter ended March 2024 as against net loss of Rs 4.39 crore during the previous quarter ended March 2023. Sales rose 12.93% to Rs 101.94 crore in the quarter ended March 2024 as against Rs 90.27 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 9.05 crore in the year ended March 2024 as against net profit of Rs 1.27 crore during the previous year ended March 2023. Sales declined 0.77% to Rs 367.35 crore in the year ended March 2024 as against Rs 370.20 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales101.9490.27 13 367.35370.20 -1 OPM %11.480.27 -4.736.95 - PBDT7.80-2.90 LP 3.5713.20 -73 PBT3.94-5.65 LP -11.062.21 PL NP3.55-4.39 LP -9.051.27 PL Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 21 May 2024Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 15 March 2024.Powered by Capital Market - Live News

Net profit of Mangalam Drugs and Organics rose 16.28% to Rs 0.50 crore in the quarter ended December 2023 as against Rs 0.43 crore during the previous quarter ended December 2022. Sales rose 54.22% to Rs 97.05 crore in the quarter ended December 2023 as against Rs 62.93 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales97.0562.93 54 OPM %7.1810.30 - PBDT3.663.39 8 PBT0.040.51 -92 NP0.500.43 16 Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News